RMD vs TMCI · P/E 29, rev $5.65B vs rev $92.6M
ResMed Inc (RMD) versus Treace Medical Concepts Inc (TMCI) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Treace Medical Concepts Inc (TMCI) is a medical devices company listed on NASDAQ.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported TMCI revenue for 2026-06-30 was $92.6M. Net income was -$33.8M. Revenue was up 96.1% from 2026-03-31 to 2026-06-30. TMCI currently screens at market cap $260.1M.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. TMCI currently screens at market cap $260.1M.
Not investment advice. Open the RMD and TMCI stock pages for the full models.
Not investment advice.